Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?

TheFly reported connected June 16 that BIOA announced the dosing of the archetypal subordinate successful QUELL-CV, a Phase 2 proof-of-concept survey evaluating BGE-102. The investigational therapy is simply a potent, orally available, brain-penetrant tiny molecule NLRP3 inhibitor designed for once-daily administration. BIOA is processing BGE-102 with cardiovascular hazard simplification arsenic its pb therapeutic focus. The initiation of the QUELL-CV proceedings represents advancement successful advancing the company's objective programme targeting cardiovascular illness pathways.

BioAge Labs, Inc. (NASDAQ:BIOA) antecedently reported its archetypal 4th 2026 fiscal results connected May 8, highlighting the continued advancement of its therapeutic programs focused connected cardiometabolic diseases and aging biology. The institution shared advancement from its BGE-102 program, wherever Phase 1 information showed beardown reductions successful hsCRP levels, including median decreases of 86% from baseline crossed evaluated dose groups. BGE-102 was good tolerated with nary superior adverse events reported. BIOA plans to statesman a Phase 2 dose-ranging survey successful participants with elevated cardiovascular hazard successful mid-2026. During the quarter, collaboration gross reached $2.8 million, portion probe and improvement expenses accrued to $20.4 million. As of March 31, 2026, BIOA held astir $384.9 cardinal successful cash, currency equivalents, and marketable securities.

BioAge Labs, Inc. (NASDAQ:BIOA) is simply a clinical-stage biopharmaceutical institution utilizing AI and longevity probe to make therapies targeting aging-related metabolic and cardiovascular diseases.

While we admit the imaginable of BIOA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.